Iconovo
1 known investors
Iconovo develops inhaled medicines in partnership with pharmaceutical companies, combining patented dry powder inhaler platforms with dry powder formulation expertise for end-to-end drug development. Based in Sweden, it works across respiratory and systemic inhalation applications, including an inhaled semaglutide program, and is listed on Nasdaq First North Growth Market.
BiotechHealthtechMedical Devices
Investors · 1
Frequently asked questions
- What does Iconovo do?
- Iconovo develops inhaled medicines in partnership with pharmaceutical companies, combining patented dry powder inhaler platforms with dry powder formulation expertise for end-to-end drug development. Based in Sweden, it works across respiratory and systemic inhalation applications, including an inhaled semaglutide program, and is listed on Nasdaq First North Growth Market.
- Who are Iconovo's investors?
- Iconovo's investors include FSG.